Postoperative residual curarization
From Wikipedia, the free encyclopedia
| Postoperative residual curarization | |
|---|---|
| Electromyographic monitoring at the adductor pollicis muscle. | |
| Specialty | Anesthesia |
Postoperative residual curarization (PORC) or residual neuromuscular blockade (RNMB) is a residual paresis after emergence from general anesthesia that may occur with the use of neuromuscular-blocking drugs.[1][2] Today residual neuromuscular blockade is defined as a train of four ratio[3] of less than 0.9 when measuring the response to ulnar nerve stimulation at the adductor pollicis muscle using mechanomyography or electromyography.[4] A meta-analysis reported that the incidence of residual neuromuscular paralysis was 41% in patients receiving intermediate neuromuscular blocking agents during anaesthesia.[1] It is possible that > 100,000 patients annually in the USA alone, are at risk of adverse events associated with undetected residual neuromuscular blockade.[5] Neuromuscular function monitoring and the use of the appropriate dosage of sugammadex to reverse blockade produced by rocuronium can reduce the incidence of postoperative residual curarization. In this study, with usual care group receiving reversal with neostigmine resulted in a residual blockade rate of 43%.[6]
Multiple studies have demonstrated that incomplete reversal of NMBDs is an important risk factor for postoperative morbidity and mortality. Multiple studies have shown that postoperative residual curarization in the post-anesthesia care unit (PACU) is a common complication, with 40% of patients exhibiting signs of residual paralysis. The incidence of this complication continues to be high and does not seem to be decreasing over time.[7]
Types of neuromuscular blocking agents
Classified into two main groups:
•Depolarizing NMBDs: produces skeletal muscle relaxation by binding directly with nAChRs to cause prolonged depolarization.
•Non-depolarizing NMBDs: competitive antagonists (competing with acetylcholine [ACh] for the binding sites at the nAChRs), preventing the initiation of action potential.[8]
Non-depolarizing neuromuscular blocking agents
Non-depolarizing NMBAs are classified based on their duration of action (short, intermediate, or long-acting agents. The two most commonly used non-depolarizing NMBDs in the operating room are rocuronium and vecuronium. Both are intermediate-acting, steroidal NMBAs. Vecuronium and rocuronium can be reversed by anticholinesterases (neostigmine) or sugammadex. If sufficient spontaneous recovery has not been achieved, neostigmine (or sugammadex) should be administered.[9]
Depolarizing neuromuscular blocking agents
Succinylcholine is the only depolarizing NMBA available for clinical use. It produces a neuromuscular blockade that is the fastest in onset and has the shortest duration of all NMBDs. Due to these properties, succinylcholine is often used for rapid sequence induction and intubation. When a continuous infusion, repeated doses, or a large dose of succinylcholine (>4 mg/kg) is used, the risk of a Phase II block and prolonged paralysis is increased. This type of block occurs when the desensitizing phase sets in and the muscle is no longer responsive to acetylcholine and full neuromuscular blockade is achieved. TOF fade is indicative of phase II block that is likely to occur in patients who received succinylcholine and may resemble features of a nondepolarizing block. During phase II, reversal with neostigmine should not be attempted. Anticholinesterase agents can worsen paralysis in this setting.[10] Prolonged paralysis after succinylcholine administration may be due to butyrylcholinesterase (pseudocholinesterase) deficiency and may require prolonged mechanical ventilation. Unlike non-depolarizing NMBDs, reversal with neostigmine should not be attempted and sugammadex will have no effect on recovery.[11]
Adverse events from inadequate neuromuscular blockade reversal
Inadequate reversal of NMBAs is an important risk factor for anesthesia related complications. Even small degrees of residual paralysis are associated with weakness of upper airway muscles which may lead to airway obstruction and increased risk of aspiration. The hypoxic ventilatory response (HRV) can also be severely depressed as well leading to hypoxemia and need for reintubation.[7] Studies have shown that incomplete neuromuscular recovery is associated with an increased risk of pulmonary complications. A prospective observational study including patients who underwent general anesthesia for noncardiac surgery reported that the "use of NMBAs was independently associated with an increase in postoperative pulmonary complications within 28 days of surgery."[12]